Doxorubicin Unknown Status Phase 2 Trials for Hepatocellular,Carcinoma

IndicationsStatusPurposePhase
Unknown StatusNot Available2
clinicaltrials.gov IdentifierTitleDrugs
NCT00990860Study in Asia of the Combination of TACE With Sorafenib in HCC Patients